ADVERTISEMENT

European Stocks Cling to Gains as Trump Plans Emergency Measures

European Stocks Stage Rebound in Worst Week Since 2008 Crisis

(Bloomberg) --

European equities all but gave up gains on Friday after a report that U.S. President Donald Trump plans to declare a national emergency over the virus outbreak overshadowed optimism on policy responses in Europe.

The Stoxx 600 Index ended the session with up 1.4%, after earlier rallying as much as 8.8% as Germany pledged to spend “billions” to help cushion the blow from the pandemic. Trump plans to declare a national emergency, invoking an act that will open the door to more federal aid for states and municipalities, people familiar with the matter said, before a scheduled news conference at 3 p.m. in Washington.

The Italian FTSE MIB Index was an outperformer, though it more than halved earlier gains. Germany’s DAX Index was up 0.8% after briefly erasing gains that reached 9% at one point. Travel and leisure stocks were the biggest decliners, down 2.4%, on worries over the impact of restrictions on freedom of movement on businesses.

“Until volatility starts coming down, we recommend investors maintain a cautious stance,” Alastair Pinder, a global equity strategist at HSBC Securities, said by phone. “We remain cautious on Europe and despite the sell-off, it’s not the right time to be going into buying European equities.”

European Stocks Cling to Gains as Trump Plans Emergency Measures

European stocks plummeted the most on record on Thursday, after a U.S. travel ban and an underwhelming European Central Bank response did little to calm investors seeking a strong, coordinated effort to deal with the pandemic’s impact on global growth.

Indications from Germany that it will abandon its long-standing balanced-budget policy if necessary appeared to help sentiment earlier today, while a European Union executive said the bloc is ready to trigger a crisis clause allowing fiscal stimulus.

Among notable movers, Roche Holding AG advanced after the Swiss drugmaker won approval from the U.S. government for a highly automated coronavirus test.

READ: Strategist Who Foresaw Market Slump Says Sell-Off Went Too Far

--With assistance from Kit Rees, Michael Msika and Ksenia Galouchko.

To contact the reporters on this story: Namitha Jagadeesh in London at njagadeesh@bloomberg.net;Jan-Patrick Barnert in Frankfurt at jbarnert3@bloomberg.net

To contact the editors responsible for this story: Celeste Perri at cperri@bloomberg.net, Jon Menon

©2020 Bloomberg L.P.